The large-scale price increase of Chinese medicinal materials in this area has made it an industry consensus to improve forecasting and control capabilities

Chinese medicinal materials are a precious resource of the Chinese nation and the source of the cause of Chinese medicine
.
In recent years, as the market's demand for traditional Chinese medicine continues to increase, and the country vigorously promotes the strategic position of traditional Chinese medicine and promotes traditional Chinese medicine services, it has also begun to indirectly drive the continuous development of the Chinese herbal medicine market
.
It is reported that since the beginning of this year, the prices of Chinese medicinal materials have continued to rise strongly, showing a general upward trend
.
Among them, the Chinese herbal medicine market in Chengdu, Sichuan, which is one of the large-scale Chinese herbal medicine markets, has seen a significant increase in the price of nearly 80% of Chinese medicines recently, and the price increase of individual varieties has even reached 200% to 300%
.
According to the merchant, “Lily may have increased by more than ten yuan per kilogram, and ginseng has increased by one hundred yuan per kilogram
.
It used to sell for more than three hundred yuan, and now it sells for more than four hundred yuan.
The price increase began when new products were produced
.
” The increase in Eclipta prostrata and Rehmannia glutinosa is also very large.
Eclipta prostrata has increased from RMB 6 per kilogram to RMB 167 per kilogram now, which is almost three times the increase
.
The purchase price of Rehmanniae in June was 22,23 yuan per kilogram, and as of the 26th, the market price had reached fifty yuan per kilogram
.
In fact, the price changes of medicinal materials are actually a normal market phenomenon, and there are many factors that affect the price changes of Chinese medicinal materials
.
Regarding the recent increase in the price of a large number of medicinal materials in the lotus pond Chinese medicinal material market, industry analysts believe that it is mainly caused by the imbalance of supply and demand
.
On the one hand, the prices of some Chinese medicinal materials were relatively poor in the past few years, and many farmers in the producing areas have reduced their varieties.
In the case of reduced production, some prices have rebounded this year.
For example, the price increase of rehmannia glutinosa is particularly severe; The production area was affected by the rain disaster, and its Shanxi production area was recently affected by the disaster, which caused the overall price of Chinese medicinal materials to rise
.
But regardless of these factors, the industry predicts that the price increase of Chinese medicinal materials in the future to a large extent should also be a long-term trend
.
As the role of Chinese medicinal materials in treating and preventing infections is recognized, used and exported overseas by more people, demand will continue to grow
.
However, due to natural conditions, it is difficult for the output of Chinese medicinal materials to increase significantly, so price increases will be expected
.
In addition, the state's new quality requirements for medicinal materials will also eliminate a large number of unqualified Chinese medicinal materials and increase the cost of medicinal materials
.
Under the background that the price increase of Chinese medicinal materials will be a long-term trend, the industry generally believes that Chinese medicine companies need to strengthen the monitoring of market prices to improve their control and forecasting capabilities of market conditions
.
It is understood that, in fact, a large number of pharmaceutical companies have already started operations
.
For example, the announcement disclosed by Tus Pharmaceuticals earlier showed that on the one hand, the company is strengthening market price monitoring and analysis, and actively carrying out strategic reserve procurement of key raw materials to reduce procurement costs; on the other hand, it is also building a bulk raw material procurement platform.
To achieve centralized procurement of some raw and auxiliary materials and packaging materials; to reduce the overall cost of the industrial chain by improving the accuracy of production forecasts and optimizing resources
.
In general, Chinese medicinal materials are fundamental to the development of the Chinese medicine industry, and changes in their price trends will affect all Chinese medicine companies
.
Judging from the fact that relevant companies are currently strengthening market price monitoring and improving their ability to control and predict market conditions, the impact of price fluctuations of Chinese medicinal materials on companies in the future may be under control
.
Small and medium-sized enterprises may be affected to a certain extent, but it is expected to be controlled by measures such as improving processes
.